The DOI matches its OpenAlex record; 38 of the 38 references it cites were found in a registry or an index.
GFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and Outcome
Abstract
Research indicates that glial fibrillary acidic protein (GFAP), part of the astroglial skeleton, could be a marker of traumatic brain injury (TBI). S100B, an astroglial protein, is an acknowledged marker of TBI. Our goal was to analyze the relationship of GFAP/S100B to brain damage and outcome, and to compare the accuracy of GFAP/S100B for prediction of mortality after TBI. Our prospective study included 92 patients admitted <12 h after TBI (median injury severity score 25, median Glasgow Coma Scale 6). TBI was verfied by computerized tomography. GFAP/S100B were measured immunoluminometrically at admission and daily in the intensive care unit (average 10 days, range 1-21 days). We compared GFAP/S100B in non-survivors versus survivors, accuracy for mortality prediction according to receiver operated characteristic curve analysis, correlation between GFAP and S100B, relationship of GFAP/S100B to computerized tomography, cerebral perfusion pressure (CPP), mean arterial pressure (MAP) and 3-month Glasgow Outcome Score (GOS). GFAP (p < 0.005) and S100B (p < 0.0005) were higher in non-survivors than survivors. Both GFAP and S100B were accurate for mortality prediction (area under curve 0.84 versus 0.78 at <12 h after TBI). GFAP and S100B release correlated better later than 36 h after TBI (r = 0.75) than earlier (r = 0.58). GFAP was lower in focal lesions of <25 mL than in shifts of >0.5 cm (p < 0.0005) and non-evacuated mass lesions of >25 mL (p < 0.005). S100B was lower in focal lesions of <25 mL than in non-evacuated mass lesions (p < 0.0005) and lower in swelling than in shifts of >0.5 cm (p < 0.005). GFAP and S100B were lower in ICP < 25 than ICP > or = 25 (p < 0.0005), in CPP > or = 60 than CPP < 60 (p < 0.0005), in MAP > 70 than MAP < or = 70 mm Hg, and in GOS 4-5 than GOS 1 (p < 0.0005). Both measurement of GFAP and S100B is a useful non-invasive means of identifying brain damage with some differences based on the pattern of TBI and accompanying multiple trauma and/or shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
An acidic protein isolated from fibrous astrocytes
Eng, L. F., Vanderhaeghen, J. J., Bignami, A., & Gerstl, B. (1971) · Brain Research · doi:10.1016/0006-8993(71)90668-8 · Cited by 1,230 · cited 1×
“G LIAL FIBRILLARY ACIDIC PROTEIN (GFAP), a monomeric intermediate filament protein found in the astroglial skeleton, was first isolated by Eng et al. (1971).”
The S100 protein family: History, function, and expression
Zimmer, D. B., Cornwall, E. H., Landar, A., & Song, W. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00040-2 · Cited by 927
S100 proteins structure functions and pathology
Heizmann, C. W. (2002) · Frontiers in Bioscience · doi:10.2741/a846 · Cited by 706
Persson, L., Hårdemark, H. G., Gustafsson, J., Rundström, G., Mendel-Hartvig, I., Esscher, T., & Påhlman, S. (1987) · Stroke · doi:10.1161/01.str.18.5.911 · Cited by 486
Blow, O., Magliore, L., Claridge, J. A., Butler, K., & Young, J. S. (1999) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199911000-00028 · Cited by 458
Missler, U., Wiesmann, M., Friedrich, C., & Kaps, M. (1997) · Stroke · doi:10.1161/01.str.28.10.1956 · Cited by 456
S100 proteins: structure, functions and pathology
Heizmann, C. (2002) · Frontiers in Bioscience · doi:10.2741/heizmann · Cited by 413
Herrmann, M., Vos, P., Wunderlich, M. T., de Bruijn, C. H. M. M., & Lamers, K. J. B. (2000) · Stroke · doi:10.1161/01.str.31.11.2670 · Cited by 400
S100β Induces Neuronal Cell Death Through Nitric Oxide Release from Astrocytes
Hu, J., Ferreira, A., & Van Eldik, L. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062294.x · Cited by 336
Serum S-100β as a possible marker of blood–brain barrier disruption
Kapural, M., Krizanac-Bengez, L., Barnett, G., Perl, J., Masaryk, T., Apollo, D., Rasmussen, P., Mayberg, M. R., & Janigro, D. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02586-6 · Cited by 284
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults
Rosengren, L. E., Wikkelsø, C., & Hagberg, L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90011-6 · Cited by 256
Serum S-100B Protein in Severe Head Injury
Raabe, A., Grolms, C., Sorge, O., Zimmermann, M., & Seifert, V. (1999) · Neurosurgery · doi:10.1097/00006123-199909000-00012 · Cited by 239
Self-citationMissler, U., Wiesmann, M., Wittmann, G., Magerkurth, O., & Hagenström, H. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.1.138 · Cited by 204
Pleines, U. E., Morganti-Kossmann, M. C., Rancan, M., Joller, H., Trentz, O., & Kossmann, T. (2001) · Journal of Neurotrauma · doi:10.1089/089771501300227297 · Cited by 203
HERRMANN, M., JOST, S., KUTZ, S., EBERT, A. D., KRATZ, T., WUNDERLICH, M. T., & SYNOWITZ, H. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.113 · Cited by 178
S100a0 (αα) Protein Is Present in Neurons of the Central and Peripheral Nervous System
Isobe, T., Takahashi, K., & Okuyama, T. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05415.x · Cited by 155
Baydaş, G., Nedzvetsky, V. S., Tuzcu, M., Yaşar, A., & Кириченко, С. В. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01294-9 · Cited by 153
Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources
Anderson, R. E., Hansson, L., Nilsson, O., Liška, J., Settergren, G., & Vaage, J. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(01)02399-2 · Cited by 143
Biochemical Serum Markers of Traumatic Brain Injury
Ingebrigtsen, T., & Romner, B. (2002) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200204000-00038 · Cited by 132
Head injury outcome prediction in the emergency department: a role for protein S-100B?
Townend, W., Guy, M. J., Pani, M. A., Martin, B., & Yates, D. W. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.5.542 · Cited by 110
Petzold, A., Green, A. J. E., Keir, G., Fairley, S., Kitchen, N. D., Smith, M., & Thompson, E. J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200212000-00015 · Cited by 102
Noppe, M., Crols, R., Andries, D., & Löwenthal, A. (1986) · Clinica Chimica Acta · doi:10.1016/0009-8981(86)90275-5 · Cited by 96
Chatfield, D. A., Zemlan, F. P., Day, D. J., & Menon, D. K. (2002) · British Journal of Neurosurgery · doi:10.1080/0268869021000030285 · Cited by 73
GFAP and S100β Expression in the Cortex and Hippocampus in Response to Mild Cortical Contusion
Hinkle, D. A., Baldwin, S. A., Scheff, S. W., & Wise, P. M. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.729 · Cited by 68
Measurement of glial fibrillary acidic protein in blood: an analytical method
van Geel, W. J. A., de Reus, H. P. M., Nijzing, H., Verbeek, M. M., Vos, P. E., & Lamers, K. J. B. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00330-3 · Cited by 67
Blennow, M., Hagberg, H., & Rosengren, L. (1995) · Pediatric Research · doi:10.1203/00006450-199503000-00002 · Cited by 64
McAdory, B. S., Eldik, L. J. V., & Norden, J. J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01014-2 · Cited by 62
White Matter Injury after Cerebral Ischemia in Ovine Fetuses
Petersson, K. H., Pınar, H., Stopa, E. G., Faris, R. A., Sadowska, G. B., Hanumara, R. C., & Stonestreet, B. S. (2002) · Pediatric Research · doi:10.1203/00006450-200206000-00019 · Cited by 58
Biochemical markers of neurologic injury in cardiac surgery: The rise and fall of S100β
Vaage, J., & Anderson, R. E. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.119055 · Cited by 42
Increased S100B in blood after cardiac surgery is a powerful predictor of late mortality
Johnsson, P., Bäckström, M., Bergh, C., Jönsson, H., Lührs, C., & Alling, C. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04318-7 · Cited by 37
Neurochemical Characterization of Traumatic Brain Injury in Humans
Regner, A., Alves, L. B., Chemale, I., Costa, M. S., Friedman, G., Achaval, M., Leal, L., & Emanuelli, T. (2001) · Journal of Neurotrauma · doi:10.1089/089771501316919148 · Cited by 35
Valentim, L. M., Michalowski, C. B., Gottardo, S. P., Pedroso, L. S., Gestrich, L. G., Netto, C. A., Salbego, C. G., & Rodnight, R. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00707-6 · Cited by 34
Albrechtsen, M., Massaro, A. R., & Bock, E. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05449.x · Cited by 34
Cited by
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 712
An update on diagnostic and prognostic biomarkers for traumatic brain injury
Wang, K. K., Yang, Z., Zhu, T., Shi, Y., Rubenstein, R., Tyndall, J. A., & Manley, G. T. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1428089 · Cited by 542
Norden, D. M., Muccigrosso, M. M., & Godbout, J. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.028 · Cited by 413
“CTE is a progressive degenerative disease of the brain typically found in individuals with a history of brain trauma, especially those with repeated injuries.”
BackgroundInfluentialS100 Proteins As an Important Regulator of Macrophage Inflammation
Xia, C., Braunstein, Z., Toomey, A. C., Zhong, J., & Rao, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01908 · Cited by 424
GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study
Vos, P. E., Jacobs, B., Andriessen, T. M. J. C., Lamers, K. J. B., Borm, G. F., Beems, T., Edwards, M., Rosmalen, C. F., & Vissers, J. L. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fd62d2 · Cited by 367
Metadata
- Authors
- Pelinka, L. E., Kroepfl, A., Leixnering, M., Buchinger, W., Raabe, A., & Redl, H. R.
- Venue
- Journal of Neurotrauma
- Publisher
- Mary Ann Liebert, Inc.
- Published
- 2004-11-01
- Volume
- 21
- Issue
- 11
- Pages
- 1553-1561
- ISSN
- 0897-7151 (ISSN-L)
- OpenAlex
- W2020030788
- Cited by
- 389
- References
- 38
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.